RF
BMY icon

Robbins Farley’s Bristol-Myers Squibb BMY Stock Holding History

Robbins Farley’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.8K Hold
903
– – 0.02% 80
2025
Q4 		$48.7K Buy
903
+276
+44% +$13.3K 0.02% 81
2025
Q3 		$28.3K Buy
627
+167
+36% +$7.8K 0.01% 98
2025
Q2 		$21.3K Hold
460
– – 0.01% 102
2025
Q1 		$28.1K Sell
460
-100
-18% -$5.83K 0.01% 88
2024
Q4 		$31.7K Hold
560
– – 0.02% 90
2024
Q3 		$29K Sell
560
-330
-37% -$15.5K 0.01% 89
2024
Q2 		$37K Sell
890
-142
-14% -$6.35K 0.02% 82
2024
Q1 		$56K Buy
1,032
+191
+23% +$9.73K 0.03% 76
2023
Q4 		$43.2K Sell
841
-19
-2% -$997 0.03% 79
2023
Q3 		$49.9K Sell
860
-31,721
-97% -$1.94M 0.03% 78
2023
Q2 		$2.08M Sell
32,581
-1,102
-3% -$73.9K 1.44% 32
2023
Q1 		$2.33M Buy
33,683
+1,449
+4% +$102K 1.56% 30
2022
Q4 		$2.32M Sell
32,234
-11,208
-26% -$845K 1.79% 27
2022
Q3 		$3.09M Sell
43,442
-1,094
-2% -$79.4K 2.54% 11
2022
Q2 		$3.43M Sell
44,536
-6,348
-12% -$483K 3.57% 7
2022
Q1 		$3.72M Sell
50,884
-3,705
-7% -$249K 2.8% 11
2021
Q4 		$3.4M Buy
54,589
+5,083
+10% +$298K 2.52% 16
2021
Q3 		$2.93M Sell
49,506
-5,352
-10% -$352K 2.16% 15
2021
Q2 		$3.67M Buy
54,858
+6,465
+13% +$422K 4.14% 8
2021
Q1 		$3.13M Buy
48,393
+1,682
+4% +$105K 2.76% 10
2020
Q4 		$2.9M Buy
+46,711
New +$2.87M 2.85% 10

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Robbins Farley's BMY Position: Q1 2026 in Review

Robbins Farley held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 903 shares worth $54.8K. The position accounts for 0.02% of the portfolio, ranked #80.

Robbins Farley first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.72M in Q1 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Robbins Farley held 903 shares of Bristol-Myers Squibb worth $54.8K as of Q1 2026.
  • Robbins Farley left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of Robbins Farley's portfolio in Q1 2026, its #80 holding.
  • Robbins Farley first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • Robbins Farley's Bristol-Myers Squibb position peaked at $3.72M in Q1 2022.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Robbins Farley's 13F filing for Q1 2026, filed 17 Apr 2026.